What Happens to the Body Before Chemotherapy Even Starts
Most conversations about cancer treatment focus on what happens during and after chemotherapy. But the weeks before treatment begins matter too — sometimes more than people realize.
Leukemia patients heading into induction chemotherapy (the intense first phase of treatment) often start in a physically depleted state. The disease itself has already been taxing the body. Add fear, disrupted sleep, and nutritional changes, and many patients arrive at day one of chemotherapy already struggling.
The Gap in Standard Care
Standard care before chemotherapy tends to be focused on logistics — blood tests, insurance, medication schedules. Physical conditioning, mental health support, and nutrition planning are often addressed reactively, if at all.
But in other surgical specialties — orthopedics, cardiac surgery — "prehabilitation" has become an established concept. The idea is to optimize a patient's physical and psychological state before a major medical event, so they're better equipped to handle and recover from it.
No one had rigorously tested whether that same logic applied to leukemia chemotherapy.
Three Pillars Before Treatment Begins
Researchers at a hospital in China enrolled 86 newly diagnosed leukemia patients and randomly assigned them to either a 12-week prehabilitation program or standard care.
The program had three components: structured exercise sessions (building toward cardiopulmonary fitness), individualized nutritional guidance, and psychological support addressing the emotional burden of a new cancer diagnosis. Think of it like renovating a house before a storm — rather than trying to make repairs in the middle of it.
What the Trial Measured
Patients were assessed at four points: before the program, at the start of chemotherapy, one month after chemotherapy, and three months after chemotherapy. Researchers tracked walking endurance (using a 6-minute walk test), cancer-related fatigue, anxiety and depression scores, and nutritional status.
What Changed — and When
The prehabilitation group walked further and reported less fatigue than the control group at every follow-up point after chemotherapy began. The improvement in walking distance and fatigue reduction were statistically significant and held through three months post-treatment.
Anxiety and depression levels were consistently lower in the prehabilitation group at every single follow-up time point. Nutritional status improved by three months post-chemotherapy, though it took longer to show up than some of the other benefits.
This Is Where Things Get Interesting
The study found no serious adverse events in the prehabilitation group — meaning the exercise and support program didn't cause harm, even in patients about to undergo aggressive chemotherapy.
That's an important baseline question: was it even safe? The answer appears to be yes.
What This Tells Us About Timing
Cancer care specialists have increasingly argued that treatment outcomes depend not just on the drugs given but on the patient's state going into treatment. A patient who starts chemotherapy with better cardiovascular fitness may handle the physical toll more effectively. A patient with lower anxiety may adhere better to the treatment protocol.
This trial adds real data to that argument.
If you or a family member has been diagnosed with leukemia and is waiting to begin chemotherapy, this research suggests that using that window proactively — with guided exercise, nutritional support, and mental health resources — may produce real benefits. Talk to your oncology team about whether a structured prehabilitation plan is available or appropriate.
Prehabilitation programs are not yet standard in most leukemia care settings, and this trial was small. But the evidence strongly supports asking your care team about what preparation is available.
Limitations to Keep in Mind
This was a single-center trial with 86 patients, and roughly 21% dropped out before completing the study. The trial was conducted in China at a tertiary hospital, so resources and patient populations may differ from other settings. The prehabilitation program was also multifaceted, making it hard to determine which component — exercise, nutrition, or psychological care — drove the benefits.
Larger multicenter trials are needed to validate these findings across different leukemia types and treatment centers. Researchers are also investigating whether a shorter or more targeted version of prehabilitation could deliver comparable benefits, making it feasible for patients who don't have twelve weeks before their first chemotherapy cycle.